RecruitingPhase 2NCT07393672
Effects of Hemp-Derived Cannabinoids on Menopause Symptoms
Sponsor
Washington State University
Enrollment
104 participants
Start Date
Feb 11, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of the study is to examine the impact of hemp-derived minor cannabinoids on symptoms of menopause/perimenopause.
Eligibility
Sex: FEMALEMin Age: 40 YearsMax Age: 60 Years
Plain Language Summary
Simplified for easier understanding
This trial is studying whether hemp-derived cannabinoids (CBD and other non-THC compounds from hemp) can reduce menopause symptoms such as hot flashes, sleep problems, mood changes, and anxiety. Participants will take a standardized hemp extract for several weeks and report their symptoms via a smartphone app.
**You may be eligible if...**
- You were designated female at birth and are 40 to 60 years old
- You are perimenopausal or menopausal
- You have not used cannabis regularly in the past year (and are willing to abstain for 3 months)
- You have a stable medication regimen (no changes in the past 3 months)
- You own a smartphone and have access to Zoom on a stable internet connection
**You may NOT be eligible if...**
- You are currently taking antidepressants, anti-anxiety, or antipsychotic medications
- You have a personal or family history of psychosis
- You are pregnant or breastfeeding
- You have hypotension (low blood pressure)
- You are currently undergoing chemotherapy
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGHemp-derived cannabinoids
Participants will be administered a legal product with hemp-derived cannabinoids and terpenes.
DRUGPlacebo
Participants will be administered a placebo
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07393672
Related Trials
Hot Flashes and Neurovascular Function in Women
NCT051939681 location
Amygdala Insula Retraining in the Management of Perimenopause Symptoms
NCT074274591 location
Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes
NCT067155141 location
Nitrate, Exercise and Vascular Function in Midlife Women
NCT065272481 location
12-week Magnesium Supplementation on Peri-menopause Symptoms, Cognition, Sleep, and Psychological Well-being
NCT072358781 location